Skip to content

PTSD: all studies

Page 198 of 211: studies 1,971 to 1,980 of 2,101, newest first. Back to the PTSD overview

Research

Mindfulness intervention for child abuse survivors: a 2.5-year follow-up.

Journal of Clinical Psychology October 2014 Michael D Earley, Margaret A Chesney, Joyce Frye et al.

The present study reports on the long-term effects of a mindfulness-based stress reduction (MBSR) program for adult survivors of childhood sexual abuse. Of the study participants, 73% returned to the clinic for a single-session follow-up assessment of depression, posttraumatic stress disorder (PTSD), anxiety, and mindfulness at 2.5 years. Repeated measures mixed regression analyses revealed...

DOI: 10.1002/jclp.22102 (opens in new tab) Full text (opens in new tab) Meditation Child abuse Long-term follow-up Mindfulness intervention +2

Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.

Neurobiology of Learning and Memory September 2014 Christine A Rabinak, Mike Angstadt, Maryssa Lyons et al.

Pre-extinction administration of Δ9-tetrahydrocannibinol (THC) facilitates recall of extinction in healthy humans, and evidence from animal studies suggest that this likely occurs via enhancement of the cannabinoid system within the ventromedial prefrontal cortex (vmPFC) and hippocampus (HIPP), brain structures critical to fear extinction. However, the effect of cannabinoids on the underlying...

DOI: 10.1016/j.nlm.2013.09.009 (opens in new tab) Full text (opens in new tab) Amygdala Extinction Hippocampus Ventromedial prefrontal cortex +2

Nightmares: Knowledge and attitudes in health care providers and nightmare sufferers

Journal of Public Health and Epidemiology July 31, 2014 J. Thnker, Maria Norpoth, M. Von Aspern et al. 23 citations

Chronic nightmares have a prevalence of 3 to 8% in the general population, but they seem not to play a relevant role in the health care system despite the existence of evidence-based treatments. The aim of this study was to identify nightmare-related knowledge, attitudes and coping approaches in the German mental health care system. A total of 219 health-care providers (primary care,...

Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC).

Pharmacology, Biochemistry, and Behavior July 2014 Tzur Alexander Mayer, Michael Alex Matar, Zeev Kaplan et al.

The therapeutic value of Delta-9-tetrahydrocannabinol (Δ9-THC) in the aftermath of trauma has recently raised interest. A prospective animal model for posttraumatic stress disorder was employed to assess the behavioral effects of a single dose of Δ9-THC administered intraperitoneally following exposure to psychogenic stress. Animals were exposed to predator scent stress and treated 1h later...

DOI: 10.1016/j.pbb.2014.04.014 (opens in new tab) Full text (opens in new tab) Animal model Cb1 antagonist/inverse agonist Delta-9-Tetrahydrocannabinol δ9-THC Early drug intervention +2

Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos

Revista chilena de neuro-psiquiatría June 1, 2014 S Christopher Timmermann 7 citations

El objetivo de esta revisión consiste en exponer los principales avances en la investigación reciente con sustancias psicodélicas en las neurociencias y sus aplicaciones psioterapéuticas. La acción de la psilocibina, un agonista del receptor 5-HT2A, ha sido asociada a una desactivación en la Default Mode Network (activada durante la introspección y pensamientos auto-referentes), un mayor acceso...

Pharmacological and non-pharmacological treatments for nightmare disorder.

International Review of Psychiatry April 1, 2014 Michael R Nadorff, Karen K Lambdin, Anne Germain

Interest in the treatment of nightmares has greatly increased over the last several years as research has demonstrated the clinical significance of nightmare disorder. This paper provides an overview of nightmare disorder, its clinical relevance, and the leading treatments that are available. In particular, the paper defines nightmare disorder and then summarize the recent literature examining...

Trauma-Related Altered States of Consciousness: Exploring the 4-D Model

Journal of Trauma & Dissociation March 20, 2014 Paul Frewen, Ruth A. Lanius 59 citations

Frewen and Lanius (in press) recently articulated a 4-D model as a framework for classifying symptoms of posttraumatic stress into those that potentially occur within normal waking consciousness (NWC) versus those that intrinsically represent dissociative experiences of trauma-related altered states of consciousness (TRASC). Four dimensions were specified: time-memory, thought, body, and...

DOI: 10.1080/15299732.2013.873377 (opens in new tab) Consciousness Distress Dissociative disorders Posttraumatic stress +4

A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research".

Human Psychopharmacology: Clinical and Experimental March 1, 2014 Rick Doblin, George Greer, Julie Holland et al. 48 citations

Parrott recently published a review of literature on MDMA/ecstasy. This commentary is a response to the content and tenor of his review, which mischaracterizes the literature through misstatement and omission of contrary findings, and fails to address the central controversies in the literature. The review makes several erroneous statements concerning MDMA-assisted psychotherapy, such as...

DOI: 10.1002/hup.2389 (opens in new tab) MDMA Ecstasy Therapeutic potential Controlled therapeutic contexts +6

Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness.

Annals of the American Thoracic Society February 1, 2014 Christopher E Cox, Laura S Porter, Pamela J Buck et al.

Rationale: Persistent symptoms of psychological distress represent an unmet need among intensive care unit (ICU) survivors. Objectives: We aimed to develop and pilot test a simple telephone-based mindfulness training intervention to address this population's unique needs. Methods: Open trial involving survivors of medical and surgical critical illness and their informal caregivers, using a...

From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.

Journal of Psychoactive Drugs 2014 David E Smith, Glenn E Raswyck, Leigh Dickerson Davidson

Since the discovery of its psychedelic properties in 1943, lysergic acid diethylamide (LSD) has been explored by psychiatric/therapeutic researchers, military/intelligence agencies, and a significant portion of the general population. Promising early research was halted by LSD's placement as a Schedule I drug in the early 1970s. The U.S. Army and CIA dropped their research after finding it...